SUBSCRIBE
SUBSCRIBE
News   Deals

Affymax, Inc. Sets Terms For 3.5 Million Share IPO

December 1, 2006 | 
1 min read
WASHINGTON, Nov 30 (Reuters) - Biopharmaceutical company Affymax Inc. filed with the U.S. Securities and Exchange Commission on Thursday to sell up to 3.5 million shares for between $22 and $24 per share in an initial public offering of stock.

>>> Discuss This Story

IPO
MORE ON THIS TOPIC
A hand in a medical or laboratory glove holds a laboratory flask with coins with dollar sign. Investments in laboratory research and science. Concept of profit, making money, business. Modern design. Copy space.
Gene therapy
AstraZeneca Gains More Gene Therapy AAVs in JCR Deal Worth up to $825M
July 9, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Big fish with dollar sign eating many small ones. Competition, merger, business, monopoly concept. EPS 8 vector illustration, no transparency
M&A
Merck Makes Big Respiratory Play With $10B Acquisition of Verona
July 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
July 8, 2025
 · 
1 min read
 · 
Annalee Armstrong
Social media illustration, business concept, web design
Mergers & acquisitions
Sage’s Search for Lifeline Ran Into Defiant Biogen CEO
July 3, 2025
 · 
3 min read
 · 
Annalee Armstrong